GB0115393D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number: GB0115393D0
Authority: GB; United Kingdom
Prior art keywords: chemical compounds; compounds; chemical
Prior art date: 2001-06-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0115393.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis UK Holdings Ltd

Original Assignee

Aventis Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-23

Filing date

2001-06-23

Publication date

2001-08-15

2001-06-23 Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd

2001-06-23 Priority to GBGB0115393.1A priority Critical patent/GB0115393D0/en

2001-08-15 Publication of GB0115393D0 publication Critical patent/GB0115393D0/en

2002-06-21 Priority to HU0400300A priority patent/HUP0400300A3/en

2002-06-21 Priority to EEP200400003A priority patent/EE05432B1/en

2002-06-21 Priority to CNB028119320A priority patent/CN1294135C/en

2002-06-21 Priority to EP02740895A priority patent/EP1404676A1/en

2002-06-21 Priority to YU99203A priority patent/RS51698B/en

2002-06-21 Priority to AU2002314325A priority patent/AU2002314325B8/en

2002-06-21 Priority to JP2003507098A priority patent/JP4344607B2/en

2002-06-21 Priority to CZ20033443A priority patent/CZ20033443A3/en

2002-06-21 Priority to BR0210652-3A priority patent/BR0210652A/en

2002-06-21 Priority to NZ529766A priority patent/NZ529766A/en

2002-06-21 Priority to MXPA03011998A priority patent/MXPA03011998A/en

2002-06-21 Priority to OA1200300335A priority patent/OA12632A/en

2002-06-21 Priority to EA200400073A priority patent/EA007415B1/en

2002-06-21 Priority to UA2004010502A priority patent/UA76760C2/en

2002-06-21 Priority to APAP/P/2003/002929A priority patent/AP2003002929A0/en

2002-06-21 Priority to SK1588-2003A priority patent/SK15882003A3/en

2002-06-21 Priority to IL15950602A priority patent/IL159506A0/en

2002-06-21 Priority to TNPCT/GB2002/002835A priority patent/TNSN03144A1/en

2002-06-21 Priority to KR1020037016809A priority patent/KR100875380B1/en

2002-06-21 Priority to HK05100184.1A priority patent/HK1068134B/en

2002-06-21 Priority to MEP-193/08A priority patent/MEP19308A/en

2002-06-21 Priority to PCT/GB2002/002835 priority patent/WO2003000695A1/en

2002-06-21 Priority to PL02374096A priority patent/PL374096A1/en

2002-06-21 Priority to HR20031049A priority patent/HRP20031049A2/en

2002-06-21 Priority to TR2003/02242T priority patent/TR200302242T2/en

2002-06-21 Priority to CA002451932A priority patent/CA2451932C/en

2003-12-10 Priority to CR7193A priority patent/CR7193A/en

2003-12-15 Priority to BG108453A priority patent/BG108453A/en

2003-12-16 Priority to MA27444A priority patent/MA27129A1/en

2003-12-19 Priority to NO20035728A priority patent/NO20035728L/en

2003-12-22 Priority to CO03111600A priority patent/CO5540313A2/en

2003-12-22 Priority to IL159506A priority patent/IL159506A/en

2003-12-23 Priority to EC2003004922A priority patent/ECSP034922A/en

2003-12-23 Priority to US10/744,478 priority patent/US7259154B2/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

GBGB0115393.1A 2001-06-23 2001-06-23 Chemical compounds Ceased GB0115393D0 (en)

Priority Applications (35)

Application Number	Priority Date	Filing Date	Title
GBGB0115393.1A GB0115393D0 (en)	2001-06-23	2001-06-23	Chemical compounds
CA002451932A CA2451932C (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
SK1588-2003A SK15882003A3 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
IL15950602A IL159506A0 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
CNB028119320A CN1294135C (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
EP02740895A EP1404676A1 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
YU99203A RS51698B (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as Protein Kinase Inhibitors
AU2002314325A AU2002314325B8 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
JP2003507098A JP4344607B2 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
CZ20033443A CZ20033443A3 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
BR0210652-3A BR0210652A (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
NZ529766A NZ529766A (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
MXPA03011998A MXPA03011998A (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors.
OA1200300335A OA12632A (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors.
EA200400073A EA007415B1 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
UA2004010502A UA76760C2 (en)	2001-06-23	2002-06-21	Pyrrole pyrimidines as protein kinase inhibitors
APAP/P/2003/002929A AP2003002929A0 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
HU0400300A HUP0400300A3 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
TNPCT/GB2002/002835A TNSN03144A1 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
EEP200400003A EE05432B1 (en)	2001-06-23	2002-06-21	P rrolop rimidines as protein kinase inhibitors
KR1020037016809A KR100875380B1 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidine as a Protein Kinase Inhibitor
HK05100184.1A HK1068134B (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
MEP-193/08A MEP19308A (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
PCT/GB2002/002835 WO2003000695A1 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
PL02374096A PL374096A1 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
HR20031049A HRP20031049A2 (en)	2001-06-23	2002-06-21	Pyrrolopyrimidines as protein kinase inhibitors
TR2003/02242T TR200302242T2 (en)	2001-06-23	2002-06-21	Pyrolopyrimidines as protein kinase inhibitors
CR7193A CR7193A (en)	2001-06-23	2003-12-10	PIRROLOPIRIMIDINAS AS INHIBITORS OF THE KINASA PROTENINE
BG108453A BG108453A (en)	2001-06-23	2003-12-15	Pyrrolopyrimidines as protein kinase inhibitors
MA27444A MA27129A1 (en)	2001-06-23	2003-12-16	PYRROLOPYRIMIDINES AS PROTEIN KINASE INHIBITORS.
NO20035728A NO20035728L (en)	2001-06-23	2003-12-19	Pyrrolopyrimidines as protein kinase inhibitors
CO03111600A CO5540313A2 (en)	2001-06-23	2003-12-22	PIRROLOPIRIMIDINAS AS INHIBITORS OF PROTEIN QUINASA
IL159506A IL159506A (en)	2001-06-23	2003-12-22	Pyrrolopyrimidines as protein kinase inhibitors
EC2003004922A ECSP034922A (en)	2001-06-23	2003-12-23	PIRROLOPIRIMIDINES
US10/744,478 US7259154B2 (en)	2001-06-23	2003-12-23	Pyrrolopyrimidines

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0115393.1A GB0115393D0 (en)	2001-06-23	2001-06-23	Chemical compounds

Publications (1)

Publication Number	Publication Date
GB0115393D0 true GB0115393D0 (en)	2001-08-15

Family

ID=9917225

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0115393.1A Ceased GB0115393D0 (en)	2001-06-23	2001-06-23	Chemical compounds

Country Status (22)

Country	Link
EP (1)	EP1404676A1 (en)
JP (1)	JP4344607B2 (en)
CN (1)	CN1294135C (en)
AU (1)	AU2002314325B8 (en)
BR (1)	BR0210652A (en)
CA (1)	CA2451932C (en)
CZ (1)	CZ20033443A3 (en)
EA (1)	EA007415B1 (en)
EC (1)	ECSP034922A (en)
EE (1)	EE05432B1 (en)
GB (1)	GB0115393D0 (en)
HU (1)	HUP0400300A3 (en)
ME (1)	MEP19308A (en)
NZ (1)	NZ529766A (en)
OA (1)	OA12632A (en)
PL (1)	PL374096A1 (en)
RS (1)	RS51698B (en)
SK (1)	SK15882003A3 (en)
TN (1)	TNSN03144A1 (en)
TR (1)	TR200302242T2 (en)
UA (1)	UA76760C2 (en)
WO (1)	WO2003000695A1 (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI329105B (en)	2002-02-01	2010-08-21	Rigel Pharmaceuticals Inc	2,4-pyrimidinediamine compounds and their uses
GB0202679D0 (en) *	2002-02-05	2002-03-20	Glaxo Group Ltd	Novel compounds
NZ537752A (en)	2002-07-29	2006-12-22	Rigel Pharmaceuticals Inc	Use of 2,4-pyrimidinediamine compounds in the preparation of medicaments for treating autoimmune diseases
JP4886511B2 (en)	2003-07-30	2012-02-29	ライジェルファーマシューティカルズ，インコーポレイテッド	Method for treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
WO2005047289A1 (en) *	2003-11-17	2005-05-26	Pfizer Products Inc.	Pyrrolopyrimidine compounds useful in treatment of cancer
JP2007512316A (en) *	2003-11-25	2007-05-17	ファイザー・プロダクツ・インク	Method for treating atherosclerosis
US20050250829A1 (en) *	2004-04-23	2005-11-10	Takeda San Diego, Inc.	Kinase inhibitors
EP1778669A2 (en)	2004-08-18	2007-05-02	Takeda San Diego, Inc.	Kinase inhibitors
FR2876103B1 (en) *	2004-10-01	2008-02-22	Aventis Pharma Sa	NOVEL BIS-AZAINDOL DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS INHIBITORS OF KINASES
DE602005023333D1 (en)	2004-10-15	2010-10-14	Takeda Pharmaceutical	KINASE INHIBITORS
FR2878849B1 (en)	2004-12-06	2008-09-12	Aventis Pharma Sa	SUBSTITUTED INDOLES, COMPOSITIONS CONTAINING SAME, METHOD OF MANUFACTURE AND USE
CA2607901C (en)	2005-06-13	2016-08-16	Rigel Pharmaceuticals, Inc.	Methods and compositions for treating degenerative bone disorders using a syk inhibitory 2,4-pyrimidinediamine
US8119655B2 (en)	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
EP2343298B9 (en)	2005-12-13	2020-05-06	Incyte Holdings Corporation	Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
EA200970361A1 (en)	2006-10-09	2010-02-26	Такеда Фармасьютикал Компани Лимитед	KINASE INHIBITORS
RS53245B2 (en)	2007-06-13	2022-10-31	Incyte Holdings Corp	JANUS KINASE INHIBITOR SALTS (R)-3-(4-(7H-PYROLO(2,3-D) PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANE-NITRILE
CA2711777A1 (en)	2008-01-11	2009-08-13	Natco Pharma Limited	Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer drugs
PE20110223A1 (en)	2008-06-10	2011-05-07	Abbvie Inc	DERIVATIVES OF PIRROLO [2,3-e] [1,2,4] TRIAZOLO [4,3-a] PIRAZIN, AS KINASE INHIBITORS
HRP20192203T1 (en)	2009-05-22	2020-03-06	Incyte Holdings Corporation	3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
WO2010135650A1 (en)	2009-05-22	2010-11-25	Incyte Corporation	N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
WO2011018894A1 (en) *	2009-08-10	2011-02-17	Raqualia Pharma Inc.	Pyrrolopyrimidine derivatives as potassium channel modulators
TW201113285A (en)	2009-09-01	2011-04-16	Incyte Corp	Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
EP2485589A4 (en)	2009-09-04	2013-02-06	Biogen Idec Inc	HETEROARYARY INHIBITORS OF BTK
WO2011068881A1 (en) *	2009-12-01	2011-06-09	Abbott Laboratories	Novel tricyclic compounds
SI3354652T1 (en)	2010-03-10	2020-08-31	Incyte Holdings Corporation	Piperidin-4-yl azetidine derivatives as jak1 inhibitors
MY161078A (en)	2010-05-21	2017-04-14	Incyte Holdings Corp	Topical formulation for a jak inhibitor
JP5917545B2 (en)	2010-11-19	2016-05-18	インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅＨｏｌｄｉｎｇｓＣｏｒｐｏｒａｔｉｏｎ	Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
WO2012068440A1 (en)	2010-11-19	2012-05-24	Incyte Corporation	Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
CN102093364B (en) *	2011-01-07	2015-01-28	北京赛林泰医药技术有限公司	2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor
CN103476776B (en) *	2011-01-07	2016-09-28	北京赛林泰医药技术有限公司	2,4-diaminourea-6,7-dihydro-5H-pyrrolo-[2,3] pyrimidine derivatives as FAK/Pyk2 inhibitor
PE20140832A1 (en)	2011-06-20	2014-07-14	Incyte Corp	DERIVATIVES OF AZETIDINYL PHENYL, PYRIDYL OR PYRAZINYL CARBOXAMIDE AS JAK INHIBITORS
TW201313721A (en)	2011-08-18	2013-04-01	Incyte Corp	Cyclohexyl azetidine derivatives as JAK inhibitors
UA111854C2 (en)	2011-09-07	2016-06-24	Інсайт Холдінгс Корпорейшн	METHODS AND INTERMEDIATE COMPOUNDS FOR JAK INHIBITORS
IN2012CH01573A (en)	2012-04-20	2015-07-10	Advinus Therapeutics Ltd
US9193733B2 (en)	2012-05-18	2015-11-24	Incyte Holdings Corporation	Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
LT2877467T (en)	2012-07-26	2017-01-10	Glaxo Group Limited	2-(azaindol-2-yl)benzimidazoles as pad4 inhibitors
ES2889757T3 (en) *	2012-09-06	2022-01-13	Plexxikon Inc	Compounds and methods for the modulation of kinases and indications for these
TWI702057B (en)	2012-11-15	2020-08-21	美商英塞特控股公司	Sustained-release dosage forms of ruxolitinib
ES2900492T3 (en)	2013-03-06	2022-03-17	Incyte Holdings Corp	Processes and intermediates to make a JAK inhibitor
CA2901334A1 (en)	2013-03-13	2014-10-02	Abbvie Inc.	Pyridine cdk9 kinase inhibitors
WO2014159999A1 (en)	2013-03-13	2014-10-02	Abbvie Inc.	Cdk9 kinase inhibitors
WO2014139328A1 (en)	2013-03-14	2014-09-18	Abbvie Inc.	Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors
CN105189512A (en) *	2013-03-14	2015-12-23	艾伯维公司	Pyrrolopyrimindine CDK9 kinase inhibitors
MX2015012896A (en)	2013-03-14	2016-06-02	Abbvie Inc	Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors.
RS60469B1 (en)	2013-08-07	2020-07-31	Incyte Corp	Sustained release dosage forms for a jak1 inhibitor
CN104804001B9 (en) *	2014-01-24	2022-02-08	江苏柯菲平医药股份有限公司	4-substituted pyrrolo [2,3-d ] pyrimidine compounds and uses thereof
US9498467B2 (en)	2014-05-30	2016-11-22	Incyte Corporation	Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
US12365689B2 (en)	2015-10-16	2025-07-22	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11773106B2 (en)	2015-10-16	2023-10-03	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11524964B2 (en)	2015-10-16	2022-12-13	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US10550126B2 (en)	2015-10-16	2020-02-04	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11512092B2 (en)	2015-10-16	2022-11-29	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
SG11201802990RA (en)	2015-10-16	2018-05-30	Abbvie Inc	PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
US11365198B2 (en)	2015-10-16	2022-06-21	Abbvie Inc.	Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
EP4487908A3 (en)	2017-03-09	2025-01-15	AbbVie Inc.	Methods of treating crohn's disease and ulcerative colitis
US11564922B2 (en)	2017-03-09	2023-01-31	Abbvie Inc.	Methods of treating crohn's disease and ulcerative colitis
TW201924683A (en)	2017-12-08	2019-07-01	美商英塞特公司	Low dose combination therapy for treatment of myeloproliferative neoplasms
PT3746429T (en)	2018-01-30	2022-06-20	Incyte Corp	Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
EP4424328A3 (en)	2018-03-30	2024-12-04	Incyte Corporation	Treatment of hidradenitis suppurativa using jak inhibitors
SI3860998T1 (en)	2018-10-05	2024-06-28	Annapurna Bio Inc.	Compounds and compositions for treating conditions associated with apj receptor activity
US11833155B2 (en)	2020-06-03	2023-12-05	Incyte Corporation	Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4275733B2 (en) *	1996-01-23	2009-06-10	ノバルティスアクチエンゲゼルシャフト	Pyrrolopyrimidine and process for producing the same
CA2272705C (en) *	1996-11-27	2003-03-18	Pfizer Inc.	Fused bicyclic pyrimidine derivatives
PA8474101A1 (en) *	1998-06-19	2000-09-29	Pfizer Prod Inc	PYROLEUM [2,3-D] PIRIMIDINE COMPOUNDS
HRP20000885B1 (en) *	1998-06-19	2007-03-31	Pfizer Products Inc.	PIROLO [2,3-d] PYRIMIDINE COMPOUNDS
CZ2001959A3 (en) *	1998-09-18	2001-12-12	Basf Aktiengesellschaft	4-Aminopyrrolopyrimidines functioning as kinase inhibitors
JP4078074B2 (en) *	1999-12-10	2008-04-23	ファイザー・プロダクツ・インク	Pyrrolo [2,3-d] pyrimidine compound

2001
- 2001-06-23 GB GBGB0115393.1A patent/GB0115393D0/en not_active Ceased
2002
- 2002-06-21 RS YU99203A patent/RS51698B/en unknown
- 2002-06-21 PL PL02374096A patent/PL374096A1/en not_active Application Discontinuation
- 2002-06-21 EA EA200400073A patent/EA007415B1/en not_active IP Right Cessation
- 2002-06-21 OA OA1200300335A patent/OA12632A/en unknown
- 2002-06-21 CZ CZ20033443A patent/CZ20033443A3/en unknown
- 2002-06-21 TR TR2003/02242T patent/TR200302242T2/en unknown
- 2002-06-21 WO PCT/GB2002/002835 patent/WO2003000695A1/en not_active Ceased
- 2002-06-21 CN CNB028119320A patent/CN1294135C/en not_active Expired - Fee Related
- 2002-06-21 JP JP2003507098A patent/JP4344607B2/en not_active Expired - Fee Related
- 2002-06-21 AU AU2002314325A patent/AU2002314325B8/en not_active Ceased
- 2002-06-21 ME MEP-193/08A patent/MEP19308A/en unknown
- 2002-06-21 NZ NZ529766A patent/NZ529766A/en not_active IP Right Cessation
- 2002-06-21 BR BR0210652-3A patent/BR0210652A/en not_active Application Discontinuation
- 2002-06-21 HU HU0400300A patent/HUP0400300A3/en unknown
- 2002-06-21 CA CA002451932A patent/CA2451932C/en not_active Expired - Fee Related
- 2002-06-21 UA UA2004010502A patent/UA76760C2/en unknown
- 2002-06-21 TN TNPCT/GB2002/002835A patent/TNSN03144A1/en unknown
- 2002-06-21 SK SK1588-2003A patent/SK15882003A3/en not_active Application Discontinuation
- 2002-06-21 EP EP02740895A patent/EP1404676A1/en not_active Withdrawn
- 2002-06-21 EE EEP200400003A patent/EE05432B1/en not_active IP Right Cessation
2003
- 2003-12-23 EC EC2003004922A patent/ECSP034922A/en unknown

Also Published As

Publication number	Publication date
AU2002314325B8 (en)	2009-01-29
EP1404676A1 (en)	2004-04-07
ECSP034922A (en)	2004-04-28
HUP0400300A3 (en)	2010-12-28
JP4344607B2 (en)	2009-10-14
CZ20033443A3 (en)	2004-03-17
JP2005508300A (en)	2005-03-31
PL374096A1 (en)	2005-09-19
CA2451932C (en)	2009-12-29
HUP0400300A2 (en)	2007-08-28
EA007415B1 (en)	2006-10-27
NZ529766A (en)	2008-11-28
OA12632A (en)	2006-06-14
RS99203A (en)	2006-12-15
UA76760C2 (en)	2006-09-15
EA200400073A1 (en)	2004-08-26
AU2002314325B2 (en)	2009-01-08
RS51698B (en)	2011-10-31
TNSN03144A1 (en)	2005-12-23
MEP19308A (en)	2010-06-10
EE05432B1 (en)	2011-06-15
CA2451932A1 (en)	2003-01-03
SK15882003A3 (en)	2004-07-07
TR200302242T2 (en)	2004-12-21
WO2003000695A1 (en)	2003-01-03
CN1518552A (en)	2004-08-04
EE200400003A (en)	2004-02-16
WO2003000695A8 (en)	2004-03-11
CN1294135C (en)	2007-01-10
BR0210652A (en)	2004-08-10

Publication	Publication Date	Title
GB0115109D0 (en)	2001-08-15	Chemical compounds
GB0103926D0 (en)	2001-04-04	Chemical compounds
GB0103630D0 (en)	2001-03-28	Chemical compounds
GB0115393D0 (en)	2001-08-15	Chemical compounds
GB0107228D0 (en)	2001-05-16	Chemical compounds
AU2002366440A8 (en)	2003-09-09	Chemical compounds
GB0114005D0 (en)	2001-08-01	Chemical compounds
GB0108046D0 (en)	2001-05-23	Chemical compounds
GB0108793D0 (en)	2001-05-30	Chemical compounds
GB0108764D0 (en)	2001-05-30	Chemical compounds
GB0113231D0 (en)	2001-07-25	Chemical compounds
GB0106446D0 (en)	2001-05-02	Chemical compounds
GB0110797D0 (en)	2001-06-27	Chemical compounds
GB0101226D0 (en)	2001-02-28	Chemical compounds
GB0108594D0 (en)	2001-05-23	Chemical compounds
GB0104418D0 (en)	2001-04-11	Chemical compounds
GB0103628D0 (en)	2001-03-28	Chemical compounds
GB0106877D0 (en)	2001-05-09	Chemical compounds
GB0106871D0 (en)	2001-05-09	Chemical compounds
GB0108593D0 (en)	2001-05-23	Chemical compounds
GB0105077D0 (en)	2001-04-18	Chemical Compounds
GB0108654D0 (en)	2001-05-30	Chemical compounds
GB0103990D0 (en)	2001-04-04	Chemical compounds
GB0103629D0 (en)	2001-03-28	Chemical compounds
GB0109248D0 (en)	2001-05-30	Chemical compounds

Legal Events

Date	Code	Title	Description
2002-09-18	AT	Applications terminated before publication under section 16(1)